Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup herbicide causes cancer, seeking to avoid potentially billions of dollars in damages.
Bayer renews bid for US Supreme Court to curb glyphosate cases
Bayer tells US it could halt Roundup weedkiller sales over legal risks
Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation.
Bayer projects improvement in 2026 after profit decline this year
Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts.
Bayer’s shares sink to 20-year low on 2025 earnings fall forecast
Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company's shares and piling pressure on its CEO to deliver on his turnaround efforts.
Bayer investor Deka takes a stand against CEO in annual vote
Bayer shareholder Deka Investment said on Friday it would not join other large investors in supporting the healthcare and agriculture group's management at its annual general meeting.
Bayer slashes outlook as glyphosate demand weakens further
Analysts say dry weather conditions hurt farmers' demand for seeds and pesticides
Reuters – Further deterioration in demand for glyphosate-based weed killers led Bayer BAYGn.DE to cut its full-year earnings outlook and announce a 2.5 billion euro ($2.8 billion USD) write-down on glyphosate-related assets. In an unscheduled statement late on Monday, the German drugs and pesticides maker said it was projecting 2023 earnings before interest, taxes, depreciation
EU seeks revised GMO rules to loosen curbs on gene-edited crops
Countries including Canada have put gene-edited plants at a lower regulatory level than GMOs, but the conversation has been ongoing in the EU
The European Commission proposed a revision of its rules on genetically modified organisms July 5 to loosen restrictions for plants resulting from newer gene-editing technology. The EU executive said the move would allow farmers to secure access to climate or pest-resistant crops with less fertilizers or pesticides and consumers would be able to buy food with better nutritional value
Bayer under investor pressure to speed up CEO changeover
Drug and chem firm's stock in 'crisis of trust,' investor says
Frankfurt | Reuters — A top-10 shareholder in Bayer on Tuesday called on the group’s supervisory board to replace CEO Werner Baumann quickly, adding to investor pressure to restore trust and revive the German drugmaker’s sagging share price. Despite recent improvements in the company’s agriculture business and drug development prospects, Bayer shares have been weighed
Weedkiller windfall helps Bayer top profit forecasts
Reuters – Bayer has reported better-than-expected quarterly earnings as a temporary price boost for its glyphosate-based herbicides made up for a decline in sales of its stroke prevention pill Xarelto. The German company said third-quarter adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose 17.3 per cent to US$2.45 billion, above analysts’ average estimate
BASF readies for another ammonia cut
The company cut ammonia output last September and will now reduce further
Reuters – BASF, the world’s largest chemical company, is cutting ammonia production again due to soaring natural gas prices, it said July 27, with potential value-chain ramifications ranging from farming to fizzy drinks. Germany’s biggest ammonia maker, SKW Piesteritz, and number four, Ineos, also said they could not rule out production cuts as the country grapples with
Cyber-Savvy Farmer
